Pamicell Ranks High in Search... Stock Price Up 0.31%
Pharmicell is trading at 15,950 KRW as of 1:30 PM on the 19th, up 0.31% from the previous day. This represents a 21.43% decline compared to September 15. Pharmicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners are tentatively recorded as net sellers of 33,051 shares. Over the past five days, individual investors have net sold 208,329 shares, while foreigners and institutions have net bought 242,948 shares and net sold 43,027 shares, respectively.
On October 16, Pharmicell became an issue in the market due to the announcement by WHO that remdesivir is 'ineffective,' which led to a decline.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
